Location History:
- Niederweningen, CH (2018 - 2022)
- Wallisellen, CH (2023)
Company Filing History:
6 out of 4,945 
5 out of 68 
1 out of 3 Years Active: 2018-2024
Title: Christiane Neumann: Innovator in Bispecific Antigen Binding Molecules
Introduction
Christiane Neumann is a prominent inventor based in Niederweningen, Switzerland. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antigen binding molecules. With a total of 12 patents to her name, her work has the potential to revolutionize treatments for various diseases.
Latest Patents
One of her latest patents focuses on T cell activating bispecific antigen binding molecules. This invention relates to novel bispecific antigen binding molecules designed for T cell activation and re-direction to specific target cells. It includes polynucleotides encoding these molecules, as well as methods for their production and use in disease treatment. Another significant patent involves bispecific antibodies that bind both a T-cell activating antigen and a tumor antigen. This invention comprises a first Fab fragment and a second Fab fragment, with specific modifications to enhance efficacy.
Career Highlights
Christiane Neumann has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Roche Glycart AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of biomedicine.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues such as Christian Klein and Pablo Umana. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Christiane Neumann is a trailblazer in the development of bispecific antigen binding molecules, with a strong patent portfolio and a career marked by significant collaborations. Her work continues to impact the field of biomedicine and offers promising avenues for future research and treatment options.